Navigation Links
MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
Date:8/19/2007

Three Independent Clinical Trials Initiated with Teplizumab Manufactured at

MacroGenics

ROCKVILLE, Md., Aug. 2 /PRNewswire/ -- MacroGenics, Inc. announced today that its Protege trial is actively enrolling adults and children ages 8 to 35 with recent-onset type 1 diabetes. The global Phase 2/3 clinical trial will evaluate the safety and efficacy of three teplizumab dosing regimens administered at the start of the study and again at six months in individuals who are up to 12 weeks from their diagnosis of type 1 diabetes. "The initiation of the pivotal Protege study is an important milestone for MacroGenics and for the type 1 diabetes research community," stated Dr. Scott Koenig, President and CEO of MacroGenics. "It is also notable that teplizumab is the first CD3 monoclonal therapy targeting type 1 diabetes to reach this stage of clinical development."

Specifically, the Protege study will assess the ability of teplizumab to inhibit the autoimmune attack that destroys insulin-producing pancreatic beta cells in individuals with type 1 diabetes. If teplizumab is effective and has the ability to preserve or protect beta cells of the pancreas, patients may require less injected insulin and their blood glucose levels may be easier to control. Other research has shown that greater control of blood glucose levels can lead to better long-term health outcomes for patients with type 1 diabetes.

Dr. Koenig also commented, "We are pleased to announce that Dr. Kevan Herold of Yale University and Dr. Bernhard Hering of the University of Minnesota are leading additional teplizumab studies in type 1 diabetes." The AbATE and Delay studies, led by Dr. Herold, are evaluating the safety and efficacy of teplizumab in patients who have had the disease for up to one year. Dr. Hering is evaluating the use of teplizumab as an induction therapy in pancreatic islet cell transplantation.

Additional information regarding the studies i
'/>"/>

SOURCE MacroGenics, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
2. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
3. New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
4. Global Rabies Treatment May be Possible with NanoViricides Drugs
5. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... PITTSBURGH , Aug. 4, 2015  The Pittsburgh ... sciences investment firm, announced today that one of its ... to sell their Flex ® Robotic System in ... pleased or more proud of Medrobotics," said John ... have come a very long way since spinning out ...
(Date:8/4/2015)...  Sutro Biopharma today announced that it has ... president of alliance and project management. Dr. Vasquez ... of Sutro,s collaborative partnerships and the development of ... antibodies and antibody-based therapeutics targeting immuno-oncology pathways. ... of experience in the biopharmaceutical sector with expertise ...
(Date:8/4/2015)... Aug. 4, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Transdermal ... to their offering. ... - an approach used to deliver drugs ... an alternative to oral,intravascular, subcutaneous and transmucosal ...
Breaking Medicine Technology:Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3Sutro Biopharma Appoints Nicki Vasquez, Ph.D. as VP of Alliance and Project Management 2Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2
... 350+ Targeted Drugs on the Market and, in Clinical Development ... Resistance, Enhance Anticancer Effects, and Expand the Markets for ... ... 19 Identification of novel,cancer-related targets and pathways is redefining our ...
... 19 Compendia Bioscience, Inc.,today announced results of ... commitment from all major customers and the addition ... customer roster. The new,customers and existing customer commitment ... with similar growth forecasted for 2008., (Logo: ...
Cached Medicine Technology:Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 2Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 3Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 4On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 2On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 3
(Date:8/4/2015)... Dublin, Ohio (PRWEB) , ... August 04, 2015 , ... ... days of summer in the sun and preparing for the back-to-school scramble. Dublin, ... of summer is the best time for the annual dental checkup. In fact, the ...
(Date:8/4/2015)... ... 2015 , ... Members receiving care from a doctor who participates in a ... is nine percent lower -- than those members at traditional doctor practices, according to ... , “The promise of patient-centered, or value-based, care to deliver better quality care ...
(Date:8/4/2015)... San Francisco, Calif. (PRWEB) , ... August 04, ... ... services to corporations, law firms and government entities, today announced that John Munro, ... leadership team as Vice President of Managed Services Operations. , “I am thrilled ...
(Date:8/4/2015)... Montclair, NJ (PRWEB) , ... August 04, 2015 , ... ... in Arts and Health, the first of its kind in New Jersey, which starting ... College of the Arts and Graduate School partnered with Atlantic Health System, one of ...
(Date:8/4/2015)... ... August 04, 2015 , ... A new report by ... reseller channel will grow at least 6 percent in 2015, as solution providers ... greater than their OEM/vendor partners. , The 2112 Group’s 2015 Midyear Channel ...
Breaking Medicine News(10 mins):Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3
... vegetables, coffee, tea and chocolate, could slash the risk ... ,The prospective cohort study of 34,489 postmenopausal ... Journal of Clinical Nutrition, reports that high dietary intake ... of mortality from cardiovascular disease (CVD), coronary heart disease ...
... may sometimes cause a bizarre but dangerous side effect -- sleep-driving, the ... ,Those who take the pills could go on to drive cars ... taken a tablet at all. ,Also they could ... asleep, not realizing that are yet to wake up. ,Still ...
... concern about the paucity of donor bodies, which is a ... to teach anatomy to medical students. ... a 30% shortage in the number of bodies. ... encourage their patients to donate their bodies for the cause ...
... some tough time on the health front, especially on account// ... it stood on the brink of an explosive AIDS epidemic. ... number of HIV infected people could soar to 10 millions ... effective action. ,The oil-rich Xinjiang Uygur Autonomous Region ...
... be launching a major initiative to reduce infant mortality ... been announced. ,Under the scheme called The ... volunteers, along with doctors and nurses, will be given ... Health Ministry official. ,Under the scheme Accredited ...
... wipe out memories selectively from the human brain. Researchers are ... to wipe out a single specific memory from brains of ... ,If that experiment can be successfully replicated in ... help relieve sufferers of the Post-traumatic Stress Disorder (PTSD). ...
Cached Medicine News:Health News:Science Stacks Up for Flavonoids for Heart Health 2Health News:Science Stacks Up for Flavonoids for Heart Health 3
... Premier Encore's balanced, iso-centered c-arm ... device is easy to position ... Controls on the x-ray tube ... and wireless remote control provide ...
The KM-500's unique viewing and alignment window lets you observe the targeted eye from any distance. Two rechargeable batteries provide continuous uninterrupted use. Each battery provides 60 minutes...
Non-dissolvable Herrick Lacrimal Plugs provide long-term lacrimal occlusion through partial blockage of the horizontal canaliculus....
... quick freezing and quick defrosting ... system - cleans the probes ... probe tips have high conductivity ... Detachment, Glaucoma and Intra-vitreal surgery. ...
Medicine Products: